ciprofloxacin

Ciprofloxacin (Bay-09867) mainly targets bacterial DNA Gyrase (IC50=0.22-0.31 µM) and topoisomerase IV (IC50=0.3-1.9 µM). Ciprofloxacin is a highly active fluoroquinolone antibiotic.

Ciprofloxacin monohydrochloride (Bay-09867 hydrochloride) is a broad-spectrum antimicrobial carboxyfluoroquinoline.

Ciprofloxacin EP IMpurity A (Fluoroquinolonic Acid) is an antibiotic and antimicrobial agent.

Ciprofloxacin hydrochloride monohydrate (Bay-09867 hydrochloride monohydrate) is a fluoroquinolone antibiotic,is an antibiotic used to treat a number of bacterial infections

Desethylene ciprofloxacin is a major metabolite of ciprofloxacin . It is also a degradation product of ciprofloxacin that can be created through advanced oxygenation processes as a potential way to remove ciprofloxacin from wastewater. It is also created during degradation of ciprofloxacin by chlorination.

Ciprofloxacin lactate is a useful organic compound for research related to life sciences. The catalog number is T66299 and the CAS number is 97867-33-9.

Ciprofloxacin-d8 is a deuterated compound of Ciprofloxacin. Ciprofloxacin has a CAS number of 85721-33-1. Ciprofloxacin, a synthetic broad spectrum fluoroquinolone antibiotic, inhibits bacterial DNA gyrase. It is more active against Gram-negative bacteria than Gram-positive bacteria.

Ciprofloxacin-d8 Hydrochloride is a deuterated compound of Ciprofloxacin Hydrochloride. Ciprofloxacin Hydrochloride has a CAS number of 93107-08-5. Ciprofloxacin hydrochloride is a broad-spectrum antimicrobial carboxyfluoroquinoline.

Ciprofloxacin (Standard) is the standard substance of Ciprofloxacin, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Ciprofloxacin (Bay-09867) mainly targets bacterial DNA Gyrase (IC50=0.22-0.31 µM) and topoisomerase IV (IC50=0.3-1.9 µM). Ciprofloxacin is a highly active fluoroquinolone antibiotic.

Ciprofloxacin lactate (Standard) is the standard substance of Ciprofloxacin lactate, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Ciprofloxacin lactate is a useful organic compound for research related to life sciences. The catalog number is T66299 and the CAS number is 97867-33-9.

Ciprofloxacin monohydrochloride (Standard) is the standard substance of Ciprofloxacin monohydrochloride, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Ciprofloxacin monohydrochloride (Bay-09867 hydrochloride) is a broad-spectrum antimicrobial carboxyfluoroquinoline.

Ciprofloxacin-d8 Hydrochloride (Standard) is the standard substance of Ciprofloxacin-d8 Hydrochloride, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Ciprofloxacin-d8 Hydrochloride is a deuterated compound of Ciprofloxacin Hydrochloride. Ciprofloxacin Hydrochloride has a CAS number of 93107-08-5. Ciprofloxacin hydrochloride is a broad-spectrum antimicrobial carboxyfluoroquinoline.

N‐Nitrosociprofloxacin is an impurity of Ciprofloxacin.

n-acetylciprofloxacin (3-Quinolinecarboxylic acid, 7-(4-acetyl-1-piperazinyl)-1-cyclopropyl-6-fluoro-1) is inhibitor of H37Rv.

Antibacterialagent 254 (Compound 2) is an antimicrobial agent capable of eradicating 7-day-old P. aeruginosa biofilms at a concentration of 50 μM without affecting bacterial growth. Additionally, Antibacterialagent 254 enhances the efficacy of Ciprofloxacin against P. aeruginosa and upregulates the expression of the matrix-degrading enzyme genes pelA, pslG, and eddA.

Antibacterialsynergist 3 is a dual-function biofilm inhibitor with an IC50 of 0.40 μM for PAO1 and 1.45 μM for PA14. It reduces virulence in Pseudomonas aeruginosa PAO1 by inhibiting the quorum sensing (QS) system and inducing iron deficiency. Additionally, Antibacterialsynergist 3 enhances the efficacy of Tobramycin and Ciprofloxacin in a mouse wound infection model. This compound is useful for research on Pseudomonas aeruginosa infections.

PqsR-IN-3 (compound 16e) is a selective inhibitor of the pqs system (IC50=3.7 μM) and its associated virulence factor pyocyanin (IC50=2.7 μM). This compound inhibits the synthesis of bacterial biofilms and is significantly cytotoxic to Pseudomonas aeruginosa. Additionally, PqsR-IN-3 exhibits synergistic effects with various antibiotics, such as Ciprofloxacin and Tobramycin.

Antibiofilm agent-6 (Compound 26c) is a quorum sensing inhibitor with antibiofilm properties, effectively reducing the fluorescence intensity of PAO1-lasB-gfp and PAO1-pqsA-gfp in a concentration-dependent manner. It suppresses the production of pyocyanin and rhamnolipids and enhances the efficacy of ciprofloxacin in eradicating viable bacteria in a Pseudomonas aeruginosa (P. aeruginosa PAO1) infected mouse model.

Antibacterialagent 282 (Compound CP7) is a selenium-containing derivative of Ciprofloxacin that serves as an antibacterial agent. It exhibits significant activity against both Gram-positive and Gram-negative bacteria, with MICs ranging from 0.1-1.56 μg/mL and 0.1-3.13 μg/mL, respectively (MBCs are 0.2-1.56 μg/mL and 0.39-12.5 μg/mL). Additionally, Antibacterialagent 282 effectively disrupts and prevents P. aeruginosa biofilm formation and significantly inhibits the DNA gyrase of E. coli.

BV600022 is an osteoadsorptive bisphosphonate-ciprofloxacin conjugate with antibacterial activity.

PD 117588 is a quinolone against bacterial isolates from cancer patients. PD 117558 has a broad antimicrobial spectrum with excellent activity against all Gram-positive isolates (including methicillin-resistant Staphylococcus aureus, coagulase-negative st

Ro 24-6392 is an ester-linked co-drug combining ciprofloxacin and desacetylcefotaxime. Ro 24-6392 demonstrats activity against a wide spectrum of aerobic bacteria.

ABT-719 is a 2-pyridinone antimicrobial agent that is more effective against Enterococcus faecalis strains than ciprofloxacin and vancomycin, which showed resistance to ciprofloxacin and vancomycin covering a range of MIC.

IMP-1700 is an inhibitor of bacterial DNA repair.1It potentiates the activity of the quinolone antibiotic ciprofloxacin against methicillin-resistantS. aureus(MRSA) with a combination index value of 0.7. IMP-1700 inhibits the ciprofloxacin-induced bacterial SOS response, a process that repairs DNA damage, in a reporter assay in a concentration-dependent manner. It is also active againstE. coli, as well as methicillin-resistant and -sensitive S. aureus, when used alone (EC50s = 0.5, 0.21, and 3.8 μM, respectively). 1.Lim, C.S.Q., Ha, K.P., Clarke, R.S., et al.Identification of a potent small-molecule inhibitor of bacterial DNA repair that potentiates quinolone antibiotic activity in methicillin-resistant Staphylococcus aureusBioorg. Med. Chem.27(20)114962(2019)